Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany Decision Represents Early Step in Building the Company’s Foundation Internationally MENLO PARK, Calif.—January 29, 2016—Intersect

First Page		Document Content
Date: 2016-02-02 07:14:47 Medicine Intersect ENT Propel mometasone furoate implant Sinus implant Forward-looking statement Sinusitis Otorhinolaryngology Sinus Mometasone furoate		Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany Decision Represents Early Step in Building the Company’s Foundation Internationally MENLO PARK, Calif.—January 29, 2016—Intersect Add to Reading List Source URL: propelopens.com Download Document from Source Website File Size: 136,77 KB Share Document on Facebook